The content on this site is intended for healthcare professionals only
EHA 2012 advances in lymphoma; lenalidamide and beyond
Identifying drug sensitivity and resistance in acute myeloid leukaemia
Addressing the problem of adherence to treatment
Patient and doctor communication and quality of life guidelines
GFI is crucial for AML1-ETO induced acute myeloid leukemia
Signaling and targeting cellular pathways in leukaemia metabolism
Whole genome sequence analysis for acute lymphoblastic leukaemia
Use of mesenchymal stromal cells against graft-versus-host disease
Next generation sequencing and the monoclonal structure of multiple myeloma
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Assessing iron overload and toxicity
What clinicians believe they said and what patients believe they heard
